These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36010558)

  • 1. Mitochondrial Dysfunction in Individuals with Diabetic Kidney Disease: A Systematic Review.
    Flemming N; Pernoud L; Forbes J; Gallo L
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADH/NAD
    Yan LJ
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34068842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose- and Non-Glucose-Induced Mitochondrial Dysfunction in Diabetic Kidney Disease.
    Ito M; Gurumani MZ; Merscher S; Fornoni A
    Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial dysfunction in diabetic kidney disease.
    Wei PZ; Szeto CC
    Clin Chim Acta; 2019 Sep; 496():108-116. PubMed ID: 31276635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dynamics and diabetic kidney disease: Missing pieces for the puzzle of therapeutic approaches.
    Narongkiatikhun P; Chattipakorn SC; Chattipakorn N
    J Cell Mol Med; 2022 Jan; 26(2):249-273. PubMed ID: 34889040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of Mitochondrial Dysfunction in Diabetic Kidney Disease: New Perspectives from Mechanism to Therapy.
    Yang Y; Liu J; Shi Q; Guo B; Jia H; Yang Y; Fu S
    Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Targeting of Mitochondria in Diabetic Kidney Disease.
    Cleveland KH; Schnellmann RG
    Pharmacol Rev; 2023 Mar; 75(2):250-262. PubMed ID: 36781216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DsbA-L deficiency exacerbates mitochondrial dysfunction of tubular cells in diabetic kidney disease.
    Gao P; Yang M; Chen X; Xiong S; Liu J; Sun L
    Clin Sci (Lond); 2020 Apr; 134(7):677-694. PubMed ID: 32167139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of diabetic kidney disease and autophagy: A review.
    Yu J; Liu Y; Li H; Zhang P
    Medicine (Baltimore); 2023 Jul; 102(30):e33965. PubMed ID: 37505163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis.
    Bolignano D; Cernaro V; Gembillo G; Baggetta R; Buemi M; D'Arrigo G
    PLoS One; 2017; 12(6):e0178699. PubMed ID: 28570649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility.
    Qi H; Casalena G; Shi S; Yu L; Ebefors K; Sun Y; Zhang W; D'Agati V; Schlondorff D; Haraldsson B; Böttinger E; Daehn I
    Diabetes; 2017 Mar; 66(3):763-778. PubMed ID: 27899487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mitochondria-Targeted Metabolic Tubular Injury in Diabetic Kidney Disease.
    Jiang H; Shao X; Jia S; Qu L; Weng C; Shen X; Wang Y; Huang H; Wang Y; Wang C; Feng S; Wang M; Feng H; Geekiyanage S; Davidson AJ; Chen J
    Cell Physiol Biochem; 2019; 52(2):156-171. PubMed ID: 30816665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Contribution to Inflammation in Diabetic Kidney Disease.
    Mitrofanova A; Fontanella AM; Burke GW; Merscher S; Fornoni A
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics improve renal function, glucose, lipids, inflammation and oxidative stress in diabetic kidney disease: a systematic review and meta-analysis.
    Dai Y; Quan J; Xiong L; Luo Y; Yi B
    Ren Fail; 2022 Dec; 44(1):862-880. PubMed ID: 35611435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction in diabetic tubulopathy.
    Yao L; Liang X; Qiao Y; Chen B; Wang P; Liu Z
    Metabolism; 2022 Jun; 131():155195. PubMed ID: 35358497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of oxidative stress in diabetic kidney disease.
    Hakim FA; Pflueger A
    Med Sci Monit; 2010 Feb; 16(2):RA37-48. PubMed ID: 20110930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of progression of diabetic kidney disease mediated by podocyte mitochondrial injury.
    Su J; Ye D; Gao C; Huang Q; Gui D
    Mol Biol Rep; 2020 Oct; 47(10):8023-8035. PubMed ID: 32918716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KCa3.1 in diabetic kidney disease.
    Huang C; Chen XM; Pollock CA
    Curr Opin Nephrol Hypertens; 2022 Jan; 31(1):129-134. PubMed ID: 34710887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of mitochondrial fission protects podocytes from albumin-induced cell damage in diabetic kidney disease.
    Tagaya M; Kume S; Yasuda-Yamahara M; Kuwagata S; Yamahara K; Takeda N; Tanaka Y; Chin-Kanasaki M; Nakae Y; Yokoi H; Mukoyama M; Ishihara N; Nomura M; Araki SI; Maegawa H
    Biochim Biophys Acta Mol Basis Dis; 2022 May; 1868(5):166368. PubMed ID: 35202791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGC1-α in diabetic kidney disease: unraveling renoprotection and molecular mechanisms.
    Ye S; Zhang M; Tang SCW; Li B; Chen W
    Mol Biol Rep; 2024 Feb; 51(1):304. PubMed ID: 38361088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.